Analgesics (Pharmacies) - Lebanon

Revenue in the Analgesics market is projected to reach US$29.02m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.77%, resulting in a market volume of US$33.27m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$5.56 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Lebanon has witnessed significant growth in recent years, driven by changing customer preferences, emerging market trends, and local special circumstances. Customer preferences in the Analgesics (Pharmacies) market in Lebanon have shifted towards a growing demand for over-the-counter pain relief medications. This can be attributed to several factors, including the convenience and accessibility of purchasing these medications without a prescription. Additionally, customers are increasingly seeking analgesics that provide fast and effective relief from pain, making them more likely to choose products that offer immediate results. Trends in the market indicate a growing focus on natural and alternative pain relief options. This is driven by a rising awareness of the potential side effects associated with traditional analgesics and a desire for more holistic approaches to managing pain. As a result, there has been an increase in the availability and popularity of natural analgesics, such as herbal remedies and homeopathic treatments. Local special circumstances play a significant role in shaping the Analgesics (Pharmacies) market in Lebanon. The country's healthcare system is characterized by a strong reliance on pharmacies, which serve as primary points of access for healthcare services and medications. This has created a favorable environment for the growth of the analgesics market, as pharmacies are well-positioned to meet the increasing demand for pain relief medications. Underlying macroeconomic factors also contribute to the development of the Analgesics (Pharmacies) market in Lebanon. The country's population is growing, leading to an increased demand for healthcare services and medications. Additionally, rising disposable incomes and improving standards of living have made healthcare more affordable and accessible to a larger segment of the population. These factors have created a conducive environment for the expansion of the analgesics market. Overall, the Analgesics (Pharmacies) market in Lebanon is developing in response to changing customer preferences, emerging market trends, local special circumstances, and underlying macroeconomic factors. The shift towards over-the-counter pain relief medications, the growing demand for natural and alternative options, the reliance on pharmacies as primary healthcare providers, and the country's favorable macroeconomic conditions all contribute to the growth and development of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.